相似文献
1
Special Issue "Ovarian Cancer: Advances on Pathophysiology and Therapies".
Int J Mol Sci. 2024 May 13;25(10):5282. doi: 10.3390/ijms25105282.
2
Ovarian Cancer: Advances in Pathophysiology and Therapies.
Int J Mol Sci. 2023 May 18;24(10):8930. doi: 10.3390/ijms24108930.
3
Notch signaling pathway in ovarian cancer.
Int J Gynecol Cancer. 2009 May;19(4):564-6. doi: 10.1111/IGC.0b013e3181a12ed2.
4
Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Am J Obstet Gynecol. 2019 Jul;221(1):53.e1-53.e6. doi: 10.1016/j.ajog.2019.02.052. Epub 2019 Mar 5.
5
Ovarian cancer: is the news good enough?
Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:298-306. doi: 10.1111/j.1525-1438.2005.00445.x.
6
Immunotherapy in ovarian cancer.
Hum Vaccin Immunother. 2012 Sep;8(9):1179-91. doi: 10.4161/hv.20738. Epub 2012 Aug 21.
7
miRNAs and ovarian cancer: An overview.
J Cell Physiol. 2018 May;233(5):3846-3854. doi: 10.1002/jcp.26095. Epub 2017 Aug 25.
8
The clinical utility of an elevated-risk multivariate index assay score in ovarian cancer patients.
Curr Med Res Opin. 2016 Jun;32(6):1161-5. doi: 10.1080/03007995.2016.1176014. Epub 2016 Apr 20.
9
Immunotherapy for ovarian cancer: recent advances and perspectives.
Curr Opin Oncol. 2014 Sep;26(5):492-500. doi: 10.1097/CCO.0000000000000111.
10
Ovarian cancer stem cells: a new target for cancer therapy.
Biomed Res Int. 2013;2013:916819. doi: 10.1155/2013/916819. Epub 2013 Jan 30.
本文引用的文献
1
Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota.
Front Pharmacol. 2024 Mar 18;15:1368949. doi: 10.3389/fphar.2024.1368949. eCollection 2024.
2
Global epidemiology of epithelial ovarian cancer.
Nat Rev Clin Oncol. 2024 May;21(5):389-400. doi: 10.1038/s41571-024-00881-3. Epub 2024 Mar 28.
3
Emerging role of m6A modification in ovarian cancer: progression, drug resistance, and therapeutic prospects.
Front Oncol. 2024 Mar 13;14:1366223. doi: 10.3389/fonc.2024.1366223. eCollection 2024.
4
Resveratrol as a Promising Nutraceutical: Implications in Gut Microbiota Modulation, Inflammatory Disorders, and Colorectal Cancer.
Int J Mol Sci. 2024 Mar 16;25(6):3370. doi: 10.3390/ijms25063370.
5
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration, and chemoresistance of Merkel cell carcinoma cells in vitro.
Hum Cell. 2024 May;37(3):729-738. doi: 10.1007/s13577-024-01047-0. Epub 2024 Mar 19.
6
Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4.
Ther Adv Med Oncol. 2024 Feb 29;16:17588359241233225. doi: 10.1177/17588359241233225. eCollection 2024.
7
Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells.
Eur J Clin Invest. 2024 Jun;54(6):e14185. doi: 10.1111/eci.14185. Epub 2024 Mar 1.
8
Therapeutic effects of resveratrol on epigenetic mechanisms in age-related diseases: A comprehensive review.
Phytother Res. 2024 May;38(5):2347-2360. doi: 10.1002/ptr.8176. Epub 2024 Feb 29.
9
Nrf2 Mediates Effect of Resveratrol in Ischemia-reperfusion Injury.
Curr Mol Pharmacol. 2024;17:e18761429246578. doi: 10.2174/0118761429246578231130064830.
10
A comprehensive overview of recent developments on the mechanisms and pathways of ferroptosis in cancer: the potential implications for therapeutic strategies in ovarian cancer.
Cancer Drug Resist. 2023 Aug 11;6(3):547-566. doi: 10.20517/cdr.2023.49. eCollection 2023.
Zotero 插件